Pediatrics

The guidelines mark a shift in practice by recommending a multimodal approach to opioid prescribing practices.

Investigators found a significant association for febrile seizures, but not with epilepsy.

Treatment is typically tailored to the individuals, with HCT being the only curative treatment bone marrow failure, but long-term outcomes are generally poorer due to toxicities.

Investigators reported that more than half of individuals had great knowledge about protecting themselves from COVID-19.

Further trials are required to examine the long-term feasibility of intravenous immunoglobulin (IVIG) for multisystem inflammatory syndrome.

Implementation of yearly mock code training can reinforce essential knowledge and increase pharmacists’ clinical competence and confidence when faced with actual neonatal and pediatric emergencies.

The authors urge that screening, prevention, and treatment of anxiety and depression should be important health care priorities for youth who have chronic pain.

NS-050/NCNP-03 is being developed to aid individuals with confirmed gene mutations that are treatable with exon 50 skipping therapy.

Surprisingly, those with overweight BMI at diagnosis did not have a poor prognosis.

Pediatric patients weighing 20 kg to <50 kg should take 20 mg of apremilast twice daily and children weighing at least 50 kg should take 30 mg twice daily.

Pharmacists can help caregivers by recommending a healthy balanced diet containing high vitamin D intake and supplementation when needed.

Key opinion leaders provide pharmacists with essential guidance on the appropriate dosing and administration of over-the-counter medications for common pediatric conditions, while equipping them with strategies to effectively counsel parents on symptom identification, condition management, and when to seek medical advice for children's health issues.

Key opinion leaders provide pharmacists with essential guidance on the appropriate dosing and administration of over-the-counter medications for common pediatric conditions, while equipping them with strategies to effectively counsel parents on symptom identification, condition management, and when to seek medical advice for children's health issues.

Remind parents that routine exams, immunizations, and nutrition are crucial to helping children succeed.

The commencement of the phase 1 clinical trial of SAT-3247 is expected in Q3 of 2024.

The FDA also granted rare pediatric disease designation for the drug.

Pharmacists can personalize supportive care, educate patients and their caregivers, advocate for patients, and collaborate with other health care workers.

Immunization rates have not returned to pre-pandemic levels, leaving millions of children and infants at risk for measles or diphtheria, tetanus, and pertussis.

The approval marks the first oral immunotherapy treatment to mitigate allergic reactions, including anaphylaxis.

The molecule can be a potential treatment that counters effects of early-life antibiotics, which can impact the gut microbiota and increase the risk of childhood atopy and asthma.

In April 2017, the drug was approved to treat the slow loss of the ability to walk for symptomatic patients aged 3 and older who had Batten disease.

The authors emphasize that clinical research should focus on real-world difficulties, and pediatric asthma control should be seen as a health care priority.

Unique gut flora were found in children with autism spectrum disorder (ASD).

The authors emphasize that these findings suggest a need for targeted resources that help reduce boarding and promote equitable access to care.